Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 26.03
+1.02 (4.08%)
Apr 30, 2026, 12:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.88 billion as of April 29, 2026. Its market cap has increased by 48.18% in one year.
Market Cap
2.88B
Enterprise Value
4.17B
Revenue
606.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.03
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.88B, a decrease of -56.19%. That is a compound annual growth rate of -15.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.88B | 27.02% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Sito Bio-technology | 2.81B |
| Jiangsu Sihuan Bioengineering | 2.97B |
| Jilin Jian Yisheng Pharmaceutical | 2.74B |
| Suzhou Fushilai Pharmaceutical | 2.68B |
| Cabio Biotech (Wuhan) | 2.68B |
| Shanghai Universal Biotech | 2.65B |
| Landfar Bio-medicine | 3.13B |
| Shanghai Model Organisms Center | 3.13B |